Clinical Trials · NCT05833217
Obesity, Insulin Resistance, and PASC: Persistent SARS-CoV-2
- Phase
- N/A
- Recruitment status
- Recruiting
- Sponsor
- Stanford University
- Enrollment
- 55
- Start date
- Jun 2023
- Locations
- 2 sites, United States
- Primary endpoint
- Triglyceride/HDL-cholesterol ratio